Comparison of in vitro micronucleus and gene mutation assay results for p53-competent versus p53-deficient human lymphoblastoid cells

Environmental and Molecular Mutagenesis

Volumn 52, Issue 5, 2011, Pages 373-384

  Honma, Masamitsu ^a   Hayashi, Makoto ^b  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b Biosafety Research Center   (Japan)

Author keywords

In vitro genotoxicity test; P53; Spindle poison; TK6; WTK 1

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; BLEOMYCIN SULFATE; CAMPTOTHECIN; COLCHICINE; CYTARABINE; FLUOROURACIL; GRISEOFULVIN; HYDROXYUREA; METHOTREXATE; METHYLNITRONITROSOGUANIDINE; MONOCROTALINE; PROTEIN P53; THYMIDINE KINASE; VINBLASTINE SULFATE;

APOPTOSIS; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENE MUTATION; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOBLASTOID CELL LINE; MICRONUCLEUS TEST; MUTATIONAL ANALYSIS; PROTEIN DEFICIENCY;

CELL LINE; HUMANS; LYMPHOCYTES; MICRONUCLEUS TESTS; MUTAGENS; MUTATION; THYMIDINE KINASE; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA; RODENTIA;

EID: 79957908980     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20634     Document Type: Article

References (61)

1. Amundson SA, Xia F, Wolfson K, Liber HL. 1993. Different cytotoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor. Mutat Res 286: 233-241.
2. Amundson SA, Do KT, Vinikoor L, Koch-Paiz CA, Bittner ML, Trent JM, Meltzer P, Fornace AJJr. 2005. Stress-specific signatures: Expression profiling of p53 wild-type and-null human cells. Oncogene 24: 4572-4579.
3. Ashby J, Styles JA, Anderson D. 1977. Selection of an in vitro carcinogenicity test for derivatives of the carcinogen hexamethylphosphoramide. Br J Cancer 36: 564-571.
4. Au WW, Johnston DA, Collie-Bruyere C, Hsu TC. 1980. Short-term cytogenetic assays of nine cancer chemotherapeutic drugs with metabolic activation. Environ Mutagen 2: 455-464.
5. Backer LC, Allen JW, Harrington-Brock K, Campbell JA, DeMarini DM, Doerr CL, Howard DR, Kligerman AD, Moore MM. 1990. Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro. Mutagenesis 5: 541-547.
6. Bruce WR, Heddle JA. 1979. The mutagenic activity of 61 agents as determined by the micronucleus, Salmonella, and sperm abnormality assays. Can J Genet Cytol 21: 319-334.
7. Chaung W, Mi LJ, Boorstein RJ. 1997. The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair. Nucleic Acids Res 25: 992-994.
8. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ. 1995. A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356.
9. Doerr CL, Harrington-Brock K, Moore MM. 1989. Micronucleus, chromosome aberration, and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells. Mutat Res 222: 191-203.
10. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. 1996. Abnormal centrosome amplification in the absence of p53. Science 271: 1744-1747.
11. Furth EE, Thilly WG, Penman BW, Liber HL, Rand WM. 1981. Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal Biochem 110: 1-8.
12. Galloway SM, Armstrong MJ, Reuben C, Colman S, Brown B, Cannon C, Bloom AD, Nakamura F, Ahmed M, Duk S. 1987. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environ Mol Mutagen 10 (Suppl 10): 1-175.
13. Greenwood SK, Armstrong MJ, Hill RB, Bradt CI, Johnson TE, Hilliard CA, Galloway SM. 1998. Fewer chromosome aberrations and earlier apoptosis induced by DNA synthesis inhibitors, a topoisomerase II inhibitor or alkylating agents in human cells with normal compared with mutant p53. Mutat Res 401: 39-53.
14. Hastwell PW, Webster, TW, Tate, M, Billinton, N, Lynch, AM, Harvey, JS, Rees, RW, and Walmsley, RM. 2009. Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP 'GreenScreen HC' genotoxicity assay. Mutagenesis 24: 455-463.
15. Honma M, Hayashi M, Sofuni T. 1997a. Cytotoxic and mutagenic responses to X-rays and chemical mutagens in normal and p53-mutated human lymphoblastoid cells. Mutat. Res. 374: 89-98.
16. Honma M, Zhang LS, Hayashi M, Takeshita K, Nakagawa Y, Tanaka N, Sofuni T. 1997b. Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells. Mol Cell Biol 17: 4774-4781.
17. Honma M, Hayashi M, Shimada H, Tanaka N, Wakuri S, Awogi T, Yamamoto KI, Kodani N, Nishi Y, Nakadate M, Sofuni T. 1999a. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagen 14: 5-22.
18. Honma M, Zhang LZ, Sakamoto H, Ozaki M, Takeshita K, Momose M, Hayashi M, Sofuni T. 1999b. The need for long-term treatment in the mouse lymphoma assay. Mutagenesis 14: 23-29.
19. Honma M, Momose M, Sakamoto H, Sofuni T, Hayashi M. 2001. Spindle poisons induce allelic loss in mouse lymphoma cells through mitotic non-disjunction. Mutat Res 493: 101-114.
20. Honma M. 2005. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells. Environ Mol Mutagen 45: 162-176.
21. Hu T, Miller CM, Ridder GM, Aardema MJ. 1999. Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: Implications for genotoxicity testing. Mutat Res 426: 51-62.
22. IARC. 1999. IARC Monographs on Evaluation of Carcinogenic Risks to Human, Vol. 71, Part 3: Hexamethylphosphoramide. Lyon, France: International Agency for Research on Cancer. pp 1465-1481.
23. ICH. 1995. Proceedings of the Third International Conference on Harmonization of Technical Requirement for Registration of Pharmaceuticals for Human Use, Technical Symposium: Safety, Session 4: Genotoxicity Testing. In: D'Arcy PF, Harron DWG, editors. Belfast: The Queen's University. pp 303-329.
24. Ishidate MJr. 1987. Data Book of Chromosome Aberration Test in Vitro. Tokyo, Japan: IIC/Elsevier.
25. Kirkland D, Aardema M, Henderson L, Muller L. 2005. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res 584: 1-256.
26. Larizza L, Simoni G, Tredici F, De Carli L. 1974. Griseofulvin: A potential agent of chromosomal segregation in cultured cells. Mutat Res 25: 123-130.
27. Leung HW. 1994. Evaluation of the genotoxic potential of alkyleneamines. Mutat Res 320: 31-43.
28. Liber HL, Thilly WG. 1982. Mutation assay at the thymidine kinase locus in diploid human lymphoblasts. Mutat Res 94: 467-485.
29. Luan Y, Suzuki T, Palanisamy R, Takashima Y, Sakamoto H, Sakuraba M, Koizumi T, Saito M, Matsufuji H, Yamagata K, Yamaguchi T, Hayashi M, Honma M. 2007. Potassium bromate treatment predominantly causes large deletions, but not GC>TA transversion in human cells. Mutat Res 619: 113-123.
30. Matsushima T, Hayashi M, Matsuoka A, Ishidate M, Jr., Miura KF, Shimizu H, Suzuki Y, Morimoto K, Ogura H, Mure K, Koshi K, Sofuni T. 1999. Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagen 14: 569-580.
31. McCann J, Horn L, Kaldor J. 1984. An evaluation of Salmonella (Ames) test data in the published literature: Application of statistical procedures and analysis of mutagenic potency. Mutat Res 134: 1-47.
32. MHLW Data. 2010. Japan Existing Chemical Data Base: In Vitro Chromosome Aberration test of N-(Aminoethyl) ethanolamine on Cultured Chinese Hamster Cells, NIHS, Tokyo..
33. Mondello C, Giorgi R, Nuzzo F. 1984. Chromosomal effects of methotrexate on cultured human lymphocytes. Mutat Res 139: 67-70.
34. Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Clay P, Doppalapudi R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Muster W, Pant K, Kidd DA, Lorge E, Lloyd M, Myhr B, O'Donovan M, Riach C, Stankowski LFJr, Thakur AK, Van Goethem F. 2007. Mouse lymphoma thymidine kinase gene mutation assay: meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment. Mutat Res 627: 36-40.
35. Mortelmans K, Haworth S, Lawlor T, Speck W, Tainer B, Zeiger E. 1986. Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ Mutagen 8 (Suppl 7): 1-119.
36. Mosesso P, Pichierri P, Franchitto A, Palitti F. 2000. Evidence that camptothecin-induced aberrations in the G(2) phase of cell cycle of Chinese hamster ovary (CHO) cell lines is associated with transcription. Mutat Res 452: 189-195.
37. Muller L, Kikuchi Y, Probst G, Schechtman L, Shimada H, Sofuni T, Tweats D. 1999. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: Evolution, reasoning and impact. Mutat Res 436: 195-225.
38. Nakamura SI, Oda Y, Shimada T, Oki I, Sugimoto K. 1987. SOS-inducing activity of chemical carcinogens and mutagens in Salmonella typhimurium TA1535/pSK1002: Examination with 151 chemicals. Mutat Res 192: 239-246.
39. Nakano E, Ichikawa-Ryo H, Kondo S. 1982. Comparative mutability of the Ames tester strains of Salmonella typhimurium by ultraviolet radiation and by 4-nitroquinoline 1-oxide. Mutat Res 93: 35-44.
40. Negrini S, Gorgoulis VG, Halazonetis TD. 2010. Genomic instability-An evolving hallmark of cancer. Nat Rev Mol Cell Biol 11: 220-228.
41. Oberly TJ, Hoffman WP, Garriott ML. 1996. An evaluation of the twofold rule for assessing a positive response in the L5178Y TK+/- mouse lymphoma assay. Mutat Res 369: 221-232.
42. Oka H, Ikeda K, Yoshimura H, Ohuchida A, Honma M. 2006. Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines. Mutat Res 606: 52-60.
43. Olive PL, Frazer G, Banath JP. 1993. Radiation-induced apoptosis measured in TK6 human B lymphoblast cells using the comet assay. Radiat Res 136: 130-136.
44. Omori T, Honma M, Hayashi M, Honda Y, Yoshimura I. 2002. A new statistical method for evaluation of L5178Ytk(+/-) mammalian cell mutation data using microwell method. Mutat Res 517: 199-208.
45. Padmanabhan S, Tripathi DN, Vikram A, Ramarao P, Jena GB. 2009. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: Intervention of folic and folinic acid. Mutat Res 673: 43-52.
46. Parry JM, Parry EM, Bourner R, Doherty A, Ellard S, O'Donovan J, Hoebee B, de Stoppelaar JM, Mohn GR, Onfelt A, Renglin A, Schultz N, Soderpalm-Berndes C, Jensen KG, Kirsch-Volders M, Elhajouji A, Van Hummelen P, Degrassi F, Antoccia A, Cimini D, Izzo M, Tanzarella C, Adler ID, Kliesch U, Hess P. 1996. The detection and evaluation of aneugenic chemicals. Mutat Res 353: 11-46.
47. Segawa M, Nadamitsu S, Kondo K, Yoshizaki I. 1979. Chromosomal aberrations of Don lung cells of Chinese hamster after exposure to vinblastine in vitro. Mutat Res 66: 99-102.
48. Seino Y, Nagao M, Yahagi T, Hoshi A, Kawachi T, Sugimura T. 1978. Mutagenicity of several classes of antitumor agents to Salmonella typhimurium TA98, TA100, and TA92. Cancer Res 38: 2148-2156.
49. Selivanova G, Wiman KG. 1995. p53: A cell cycle regulator activated by DNA damage. Adv Cancer Res 66: 143-180.
50. Sherwood SW, Schumacher RI, Schimke RT. 1988. Effect of cycloheximide on development of methotrexate resistance of Chinese hamster ovary cells treated with inhibitors of DNA synthesis. Mol Cell Biol 8: 2822-2827.
51. Storer RD, Kraynak AR, McKelvey TW, Elia MC, Goodrow TL, DeLuca JG. 1997. The mouse lymphoma L5178Y Tk+/- cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutat Res 373: 157-165.
52. Umeda M, Saito M. 1971. The effect of monocrotaline, a pyrrolizidine alkaloid, on HeLa cells and primary cultured cells from rat liver and lung. Acta Pathol Jpn 21: 507-514.
53. Walton DG, Acton AB, Stich HF. 1984. Comparison of DNA-repair synthesis, chromosome aberrations and induction of micronuclei in cultured human fibroblasts, Chinese hamster ovary and central mudminnow (Umbra limi) cells exposed to chemical mutagens. Mutat Res 129: 129-136.
54. Wehner FC, Thiel PG, van Rensburg SJ, Demasius IP. 1978. Mutagenicity to Salmonella typhimurium of some Aspergillus and Penicillium mycotoxins. Mutat Res 58: 193-203.
55. Yajima N, Kondo K, Morita K. 1981. Reverse mutation tests in Salmonella typhimurium and chromosomal aberration tests in mammalian cells in culture on fluorinated pyrimidine derivatives. Mutat Res 88: 241-254.
56. Yamanaka H, Nagao M, Sugimura T, Furuya T, Shirai A, Matsushima T. 1979. Mutagenicity of pyrrolizidine alkaloids in the Salmonella/mammalian-microsome test. Mutat Res 68: 211-216.
57. Yarbro JW. 1992. Mechanism of action of hydroxyurea. Semin Oncol 19: 1-10.
58. Zeiger E. 1998. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance. Regul Toxicol Pharmacol 28: 85-95.
59. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K, Speck W. 1987. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ Mutagen 9 (Suppl 9): 1-109.
60. Zhang, L-S, Honma M, Hayashi M, Suzuki T, Matsuoka A, Sofuni T. 1995. A comparative study of TK6 human lymphoblastoid and L5178Y mouse lymphoma cell lines in the in vitro micronucleus test. Mutat Res 347: 105-115.
61. Zhen W, Denault CM, Loviscek K, Walter S, Geng L, Vaughan AT. 1995. The relative radiosensitivity of TK6 and WI-L2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status. Mutat Res 346: 85-92.